Bakkt, Inc.

Bakkt stock surged 21.33% on insider purchases totaling $4.85 million and announcement of commercial expansion strategy, despite reporting Q1 revenue down 77.1% year-over-year and missing analyst estimates. The company is focusing on scaling operations and expanding its digital asset position.

Bakkt (NYSE: BKKT) has completed its acquisition of Distributed Technologies Research (DTR), a developer of agentic payments and stablecoin infrastructure. The deal involved issuing 11.3 million shares of Class A Common Stock to DTR shareholders, with potential for up to 725,592 additional shares. The combined company aims to create a unified pla...

Clear Street will host a two-day, invitation-only Disruptive Technology Conference on November 19-20, 2025, at the Four Seasons Resort Palm Beach, featuring CEOs, investors, and innovators across technology sectors, with keynote speakers Michael Saylor and Eric Trump.

A securities class action lawsuit has been filed against Iovance Biotherapeutics, Inc. (IOVA) for allegedly making false and misleading statements about its business operations and prospects during the class period from May 9, 2024 to May 8, 2025. The Rosen Law Firm is encouraging investors to secure counsel before the July 14, 2025 lead plaintif...

Rosen Law Firm, a global investor rights law firm, reminds Bakkt Holdings, Inc. (BKKT) investors of the important June 2, 2025 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Bakkt made false and/or misleading statements about the stability and diversity of its crypto services revenue.